Abbott Laboratories

Name:	Abbott Laboratories
Industries:	Healthcare
Revenue:	$30.76B
Profit:	$5.75B
Headquarters:	100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK, Illinois 60064-3500 United States Of America
Website:
www.abbott.com

Lists:

#51	Highest Market Cap
#30	Best Performers In Health

¹ TTM figures for 31-Dec-2009

We are a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Our products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Our comprehensive line of products encircles life itself - addressing important health needs from infancy to the golden years. Abbott has sales, manufacturing, research and development, and distribution facilities around

We are a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Our products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Our comprehensive line of products encircles life itself - addressing important health needs from infancy to the golden years.

Abbott has sales, manufacturing, research and development, and distribution facilities around the world, close to where our customers need us to be. We are recognized for our global reach and our ability to serve our customers around the world.

... more

All News - 1000's of sources

loading news

new tracked items.

Tracker changed. Refresh? yes | no

News + Established Blogs - filter | refresh

Sources
Show all Show only: check at least one: News + Established Blogs Emerging Blogs Press Releases SEC Filings

1 hour:

Why You Should Pay Attention to Arena's Lorquess

Next week a committee of experts will give the FDA their opinion on two diet drugs -- Abbott Laboratories (ABT) Meridia and Arena Pharmaceuticals (ARNA) Lorquess. The panel's opinion will not only affect these two drugs and their companies but will have a huge impact on whether or not the pharmaceutical ... - read more at Minyanville

tags: Arena

3 hours:

The Economic Geography of Publicly-Traded Companies in the United ...

No, I'm not doing a part 3 of the “Dave” series, though I am tempted after today's events. One of the widows in our church insisted that her son contact me about a business deal he was entering into. God especially looks out for widows, so I give them extra time. Turned out to be a Nigerian-style ... - read more at David Merkel

tags: Apple Bank of America BB&T Berkshire Hathaway Chesapeake Energy Chevron Cisco Citigroup Cliffs Natural Resources CME Group ConocoPhillips Devon Energy Ecolab DuPont Equity Residential Exxon Mobil GE Goldman Sachs Google Hewlett Packard Icahn Enterprises Illinois Tool Works Johnson & Johnson J.P. Morgan Kraft Foods Microsoft Northern Trust Occidental Petroleum Oracle Philip Morris Schlumberger Sherwin Williams United Technologies Wal-Mart Wells Fargo

7 hours:

Morgan Stanley's Equity Morning Summary

Upgrades: Estacio Participacoes SA (SAO: ESTC3) upgraded from Equal to Overweight, price target remains at $25, 2010 EPS raised to $1.15 (from $1.12), 2011 raised to $1.32 (from $1.15). Downgrades: Adobe Systems (NASDAQ: ADBE) downgraded to Equal from Overweight, price target remains at $42. Boston ... - read more at Benzinga

tags: Adobe Systems (NASDAQ: ADBE) Boston Scientific (NYSE: BSX) Dell, Inc Discover Financial Services (NYSE: DFS) Microsoft Corporation (NASDAQ: MSFT) Morgan Stanley National Semiconductor (NYSE: NSM) Sprint Nextel Corporation (NYSE: N) Stryker Corporation (NYSE: SYK) Covidien (NYSE: COV) CareFusion Corp. (NYSE: CFN)

22 hours:

Abbott Included on the Dow Jones Sustainability Indexes for ...

ABBOTT PARK, Ill., Sept. 9 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today that it was included on both the Dow Jones Sustainability World Index and North America Index for the sixth consecutive year. The Dow Jones Sustainability Indexes (DJSI) recognize the leading companies in each industry ... - read more at RedOrbit

tags: Miles D. White

23 hours:

Abbott Labs Acquires Piramal Unit - Analyst Blog

Abbott Labs (ABT) recently completed its acquisition of Indian company Piramal Healthcare Ltd.'s Healthcare Solutions business (Domestic Formulations) for $3.8 billion. In addition to an upfront payment of $2.2 billion, Abbott Labs will pay $400 million annually over the next 4 years. Position Strengthened ... - read more at Benzinga

tags: Pfizer AstraZeneca (AZN) GlaxoSmithKline (GSK) Healthcare Solutions

23 hours:

FDA: Abbott Recalls Some HIV Blood Screening Tests

Abbott Laboratories (ABT) has recalled some HIV blood screening tests following customer complaints of "calibration failures," the U.S. Food and Drug Administration said Thursday. The recalled product is the Prism HIV O Plus. The number of the recalled lot is 87334M500, the FDA said. The FDA said customers ... - read more at Fox Business

tags: Dow Jones Newswires

9/9/10:

Abbott Labs Acquires Piramal Unit

Abbott Labs (ABT) recently completed its acquisition of Indian company Piramal Healthcare Ltd.???s Healthcare Solutions business (Domestic Formulations) for $3.8 billion - read more at Zacks - Analyst blog

tags: Healthcare Solutions

9/9/10:

Q: Michael J Warmuth, Sr VP, Abbott Labs, US

Abbott Laboratories became the largest domestic pharmaceutical company in terms of market share, ahead of Cipla and Ranbaxy, after completing its acquisition of Piramal Healthcare Solutions yesterday. Michael J Warmuth, senior vice president, established products, of Abbott, US, spoke to P B Jayakumar ... - read more at Business Standard

9/9/10:

Disappearing Device Keeps Arteries Open Without Metal 'Spider'

John Lamb, a retired auto mechanic in New Zealand, was the first patient to get one of Abbott Laboratories' experimental heart stents to treat chest pains. In a sense, he now has nothing to show for it -- as doctors intended all along. Abbott's stent, a scaffold-like device the size of the spring in ... - read more at Health Leaders - daily top stories

tags: Boston Scientific Corp Johnson & Johnson Medtronic Inc John Capek

9/8/10:

Similar Companies Doesn't Mean Similar Stocks

Ok class, today's lesson is on the pitfalls of similar stock performance. It's tempting to think that all companies in a certain industry group behave the same way. The reason why is that in the short term, they often do. Once you start following a sector closely, you'll see that, say, all the major ... - read more at Eddy Elfenbein

tags: Bristol-Myers Squibb Company Eli Lilly Merck Pfizer GlaxoSmithKline

see more news »

NYSE: ABT - Today, 4:04 PM ET

51.54 +0.45 (+0.88%)

Vol:	4.44M
High:	51.59
Low:	51.09

Mkt Cap:	79.56B
52Wk High:	56.79
52Wk Low:	44.59

P/E:	15.16
Div:	1.76
Yield:	3.41

1d | 1m | 3m | 6m | 1y | 5y | 10y

previous day close

Financial Performance

Income (in thousands of USD)	3 months ending 2009-12-31 00:00:00	12 months ending 2009-12-31 00:00:00
Revenue	8,790,127	30,764,707
Net Income	4,169,191	5,745,838
Balance Sheet (in thousands of USD)
Current Assets	23,313,891	23,313,891
Total Assets	52,416,623	52,416,623
Current Liabilities	13,049,489	13,049,489
Total Liabilities	29,560,996	29,560,996
Total Shareholders Equity	22,855,627	22,855,627
Cash Flow (in thousands of USD)
Cash from Operating Activity	1,832,617	7,275,160
Cash from Investing Activity	1,562,877	-3,698,710
Cash from Financing Activity	503,373	1,002,019
Change in Cash	3,933,424	4,697,317

Key Stats	3 months ending 2009-12-31 00:00:00	Trailing 12 Months
Gross Profit Margin	56.95%	57.06%
Net Profit Margin	47.43%	18.68%
Return on Assets	7.95%	10.96%
Return on Equity	18.24%	25.14%
Return on Invested Capital	4.42%	13.39%